6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
19m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
19m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
19m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
19m ago	First Quantum Minerals Reports First Quarter 2026 Results
19m ago	District Metals Announces $10 Million Private Placement Financing

About

Travere Therapeutics Inc (NASDAQ:TVTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Travere Therapeutics to Report First Quarter 2026 Financial Results

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS

Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Financials

Revenue

$490.73 M

Market Cap

$2.81 B

EPS

-0.57

Community Chat

Ask AI